Hologic, Inc.
Hologic, Inc. (HOLX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
holx · pe ratio · data through Sep 27, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hologic, Inc. (HOLX) measures how much investors pay for each dollar of the company's trailing earnings. HOLX's current PE ratio of 31.36x is calculated by dividing its stock price of $76.01 by its TTM earnings per share of $2.42. +40.7% elevated vs 5Y avg 22.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-27
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%27.0x
MedianQ3 · 75%387.5x
Max
At 31.36x, HOLX's current P/E is within its average historical range over the past 13 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hologic, Inc.You HOLX | $17.0B | 31.36x | +19.3% | $2.42 |
 Centene Corporation CNC | $31.8B | N/A | — | -$13.59 |
 The Cooper Companies, Inc. COO | $13.1B | 37.30x | +41.9% | $1.87 |
 Fresenius Medical Care AG & Co. KGaA FMS | $11.7B | 12.07x | -54.1% | $1.68 |
 Illumina, Inc. ILMN | $23.8B | 24.52x | -6.7% | $5.48 |
 Medpace Holdings, Inc. MEDP | $13.0B | 35.91x | +36.6% | $15.64 |
 Royalty Pharma plc RPRX | $23.6B | 21.65x | -17.7% | $1.79 |
Industry Average 5 peers with valid PE | — | 26.29x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-27Latest FY2025 | 26.99x | $2.49 | +11.0% | |
2024-09-30 FY2024 | 24.32x | $3.35 | -35.2% | |
2023-09-30 FY2023 | 37.56x | $1.85 | +201.3% | |
2022-09-30 FY2022 | 12.46x | $5.18 | +23.0% | |
2021-09-30 FY2021 | 10.14x | $7.28 | -35.3% | |
2020-09-30 FY2020 | 15.66x | $4.24 | — | |
2019-09-30 FY2019 | — | $-0.15 | — | |
2018-09-30 FY2018 | — | $-0.40 | — | |
2017-09-30 FY2017 | 13.59x | $2.70 | -58.7% | |
2016-09-30 FY2016 | 32.89x | $1.18 | -60.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hologic, Inc. (HOLX) measures how much investors pay for each dollar of the company's trailing earnings. HOLX's current PE ratio of 31.36x is calculated by dividing its stock price of $76.01 by its TTM earnings per share of $2.42.
Frequently asked questions
HOLX pe ratio · 6 questionsHOLX's current PE ratio is 31.36x as of 2026-06-08, based on a stock price of $76.01 and TTM EPS of $2.42. Data sourced from Financial Modeling Prep via HOLX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hologic, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08